Segui
Enzo Ierardi
Enzo Ierardi
Professore Associato di Gastroenterologia - Italy - In quiescenza
Email verificata su virgilio.it - Home page
Titolo
Citata da
Citata da
Anno
Worldwide H. pylori antibiotic resistance: a systematic
V De Francesco, F Giorgio, C Hassan, G Manes, L Vannella, C Panella, ...
J Gastrointestin Liver Dis 19 (4), 409-414, 2010
6822010
Systematic review: endoscopic dilatation in Crohn’s disease
C Hassan, A Zullo, V De Francesco, E Ierardi, M Giustini, A Pitidis, F Taggi, ...
Alimentary pharmacology & therapeutics 26 (11‐12), 1457-1464, 2007
3572007
Effects of Helicobacter pylori eradication on early stage gastric mucosa–associated lymphoid tissue lymphoma
A Zullo, C Hassan, F Cristofari, A Andriani, V De Francesco, E Ierardi, ...
Clinical gastroenterology and hepatology 8 (2), 105-110, 2010
3552010
High eradication rates of Helicobacter pylori with a new sequential treatment
A Zullo, D Vaira, N Vakil, C Hassan, L Gatta, C Ricci, V De Francesco, ...
Alimentary pharmacology & therapeutics 17 (5), 719-726, 2003
3482003
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori
V De Francesco, M Margiotta, A Zullo, C Hassan, L Troiani, O Burattini, ...
Annals of internal medicine 144 (2), 94-100, 2006
3402006
Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized trial
R Francavilla, E Lionetti, SP Castellaneta, AM Magistà, G Boscarelli, ...
Gastroenterology 129 (5), 1414-1419, 2005
2732005
Lactobacillus reuteri therapy to reduce side‐effects during anti‐Helicobacter pylori treatment in children: a randomized placebo controlled trial
E Lionetti, VL Miniello, SP Castellaneta, AM Magistá, A De Canio, ...
Alimentary pharmacology & therapeutics 24 (10), 1461-1468, 2006
2512006
Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal
V De Francesco, A Zullo, C Hassan, F Giorgio, R Rosania, E Ierardi
World journal of gastrointestinal pathophysiology 2 (3), 35, 2011
2132011
Inhibition of Helicobacter pylori Infection in Humans by Lactobacillus reuteri ATCC 55730 and Effect on Eradication Therapy: A Pilot Study
R Francavilla, E Lionetti, SP Castellaneta, AM Magistà, G Maurogiovanni, ...
Helicobacter 13 (2), 127-134, 2008
2112008
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure
V De Francesco, A Zullo, M Margiotta, S Marangi, O Burattini, P Berloco, ...
Alimentary pharmacology & therapeutics 19 (4), 407-414, 2004
1922004
Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study
O Ceci, M Margiotta, F Marello, R Francavilla, P Loizzi, A Francavilla, ...
Journal of pediatric gastroenterology and nutrition 33 (5), 570-575, 2001
1832001
Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy
V De Francesco, M Margiotta, A Zullo, C Hassan, F Giorgio, O Burattini, ...
Journal of Antimicrobial Chemotherapy 59 (4), 783-785, 2007
1792007
Guidelines for the management of Helicobacter pylori infection in Italy: the III Working Group Consensus Report 2015
RM Zagari, M Romano, V Ojetti, R Stockbrugger, S Gullini, B Annibale, ...
Digestive and Liver Disease 47 (11), 903-912, 2015
1732015
A 10‐day levofloxacin‐based triple therapy in patients who have failed two eradication courses
L Gatta, A Zullo, F Perna, C Ricci, V De Francesco, A Tampieri, ...
Alimentary pharmacology & therapeutics 22 (1), 45-49, 2005
1662005
Curcumin and colorectal cancer: from basic to clinical evidences
M Pricci, B Girardi, F Giorgio, G Losurdo, E Ierardi, A Di Leo
International journal of molecular sciences 21 (7), 2364, 2020
1642020
Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study
R Francavilla, L Polimeno, A Demichina, G Maurogiovanni, B Principi, ...
Journal of clinical gastroenterology 48 (5), 407-413, 2014
1572014
Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits
V De Francesco, A Zullo, E Ierardi, F Giorgio, F Perna, C Hassan, S Morini, ...
Journal of antimicrobial chemotherapy 65 (2), 327-332, 2010
1522010
High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study
A Zullo, L Gatta, V De Francesco, C Hassan, C Ricci, V Bernabucci, ...
Alimentary pharmacology & therapeutics 21 (12), 1419-1424, 2005
1452005
How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?
E Ierardi, F Giorgio, G Losurdo, A Di Leo, M Principi
World Journal of Gastroenterology: WJG 19 (45), 8168, 2013
1402013
The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study
V De Francesco, A Zullo, C Hassan, N Della Valle, L Pietrini, MF Minenna, ...
Digestive and liver disease 36 (5), 322-326, 2004
1322004
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20